相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sequential treatment with sildenafil and riociguat in patients with persistent or inoperable chronic thromboembolic pulmonary hypertension improves functional class and pulmonary hemodynamics
Darocha Szymon et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
Henning Gall et al.
LUNG (2018)
Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: A systematic review and meta-analysis
Sanne Arjaans et al.
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2018)
An update on the diagnosis and management of bronchopulmonary dysplasia (BPD)-associated pulmonary hypertension
Sara K. Berkelhamer et al.
SEMINARS IN PERINATOLOGY (2018)
Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
Nick H. Kim et al.
HEART (2017)
Hemodynamic instability in the critically ill neonate: An approach to cardiovascular support based on disease pathophysiology
Regan E. Giesinger et al.
SEMINARS IN PERINATOLOGY (2016)
Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety
Kenneth Tan et al.
EUROPEAN JOURNAL OF PEDIATRICS (2015)
Safety of epoprostenol and treprostinil in children less than 12 months of age
Chelsey M. McIntyre et al.
PULMONARY CIRCULATION (2013)
Targeted Neonatal Echocardiography in the Neonatal Intensive Care Unit: Practice Guidelines and Recommendations for Training
Luc Mertens et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2011)
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: Clinical features and outcomes in the surfactant era
Ekta Khemani et al.
PEDIATRICS (2007)
Disturbances in nitric oxide/cyclic guanosine monophosphate system in SHR/NDmcr-cp rats, a model of metabolic syndrome
S Kagota et al.
LIFE SCIENCES (2006)
Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling
R Dumitrascu et al.
CIRCULATION (2006)
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Oleg V. Evgenov et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells
J Wharton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis
TC Carpenter et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
Interactions of angiotensin II with MAD(P)H oxidase, oxidant stress and cardiovascular disease
DG Harrison et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2003)
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure
G Boerrigter et al.
CIRCULATION (2003)
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
HA Ghofrani et al.
LANCET (2002)
分享论文
